Published in Arch Dis Child on August 01, 1975
Monoparesis. Complication of constant positive airways pressure. Arch Dis Child (1975) 1.54
Nitrogen control in Salmonella: regulation by the glnR and glnF gene products. Proc Natl Acad Sci U S A (1979) 4.79
Diagnosis tosh. Br Dent J (2010) 4.14
Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A (1993) 3.56
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation (1986) 2.38
Gallbladder contractility in patients with spinal cord injuries: a sonographic investigation. AJR Am J Roentgenol (1990) 2.24
Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child (1997) 2.12
Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11
Food intolerance and food allergy in children: a review of 68 cases. Arch Dis Child (1982) 2.07
It is reprehensible. Br Dent J (2010) 2.03
Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet (1985) 1.86
Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol (1991) 1.84
Incidence of neonatal urinary tract infection. Arch Dis Child (1969) 1.79
Admission to hospital with asthma. Arch Dis Child (1985) 1.77
Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J Clin Microbiol (1998) 1.77
Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil (2009) 1.73
Home intravenous antibiotic treatment in cystic fibrosis. Arch Dis Child (1988) 1.72
Differential diagnosis in child sexual abuse. Lancet (1987) 1.64
AIDS vaccine development. Science (1998) 1.62
Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil (2009) 1.62
The sweat test. Arch Dis Child (1986) 1.58
Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child (1990) 1.55
Prevalence of bacteriuria in infants and preschool children. Lancet (1974) 1.53
Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut (2003) 1.53
Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis. Pediatr Pulmonol (2000) 1.50
Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child (1986) 1.49
Vitamin status in treated patients with cystic fibrosis. Arch Dis Child (1981) 1.45
Self-initiated quitting among adolescent smokers. Prev Med (1998) 1.44
Covalent modification of bacterial glutamine synthetase: physiological significance. Mol Gen Genet (1984) 1.44
Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection. Arch Dis Child (1987) 1.42
A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol Motil (2002) 1.39
Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child (1987) 1.38
The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. Circulation (1986) 1.37
Social and psychiatric functioning in adolescents with Asperger syndrome compared with conduct disorder. J Autism Dev Disord (2000) 1.36
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil (2009) 1.35
Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil (2009) 1.32
Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil (2012) 1.31
Chromogranin A: immunohistology reveals its universal occurrence in normal polypeptide hormone producing endocrine glands. Life Sci (1983) 1.30
Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol (2001) 1.29
Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet (1988) 1.29
Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut (2000) 1.23
Cystic fibrosis and allergic bronchopulmonary aspergillosis. Arch Dis Child (1990) 1.23
The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis. Arch Dis Child (1992) 1.21
Project towards no tobacco use: 1-year behavior outcomes. Am J Public Health (1993) 1.20
Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study. J Clin Microbiol (1988) 1.20
Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis. J Clin Pathol (1986) 1.19
66 infants with urinary tract infection in first month of life. Arch Dis Child (1972) 1.19
Availability of tobacco products at stores located near public schools. Int J Addict (1991) 1.19
Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (1996) 1.19
A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis. Arch Dis Child (1993) 1.16
Search for quantitative trait loci affecting growth and carcass traits in a cross population of beef and dairy cattle. J Anim Sci (2008) 1.16
Development and current functioning in adolescents with Asperger syndrome: a comparative study. J Child Psychol Psychiatry (2001) 1.15
Urinary tract infection by Trichomonas vaginalis in a newborn baby. Arch Dis Child (1966) 1.14
Physician delivery of smoking-cessation advice based on the stages-of-change model. Am J Prev Med (1995) 1.14
Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil (2009) 1.14
The Prenatal Psychosocial Profile: a research and clinical tool. Res Nurs Health (1998) 1.13
Clinical monitoring of steatorrhoea in cystic fibrosis. Arch Dis Child (1990) 1.13
Colonic strictures in cystic fibrosis. Arch Dis Child (1995) 1.13
A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther (1997) 1.11
Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH. Proteins (2001) 1.11
Reasons for quitting and smoking temptation among adolescent smokers: gender differences. Subst Use Misuse (1998) 1.10
Adolescents' first and most recent use situations of smokeless tobacco and cigarettes: similarities and differences. Addict Behav (1990) 1.10
Peer-group association and adolescent tobacco use. J Abnorm Psychol (1990) 1.09
Totally implantable venous access systems in paediatric practice. Arch Dis Child (1989) 1.09
Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy. Chest (1992) 1.08
Demographic, psychosocial and behavioral differences in samples of actively and passively consented adolescents. Addict Behav (1993) 1.08
Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil (2004) 1.07
Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child (1997) 1.06
Two tier screen for cystic fibrosis. Lancet (1981) 1.06
Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child (1990) 1.05
Campylobacter pylori gastritis. Arch Dis Child (1988) 1.05
The relationship between traumatic exposure, family dysfunction, and post-traumatic stress symptoms in male juvenile offenders. J Trauma Stress (1994) 1.05
Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax (1992) 1.04
Wantedness of pregnancy and prenatal health behaviors. Women Health (1997) 1.03
An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil (2007) 1.03
Routine colonoscopy service. Arch Dis Child (1984) 1.03
Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans. Neurogastroenterol Motil (2007) 1.03
Misdiagnosis of cystic fibrosis. Arch Dis Child (1987) 1.03
Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis. Arch Dis Child (1984) 1.03
Does the nutrient drink test accurately predict postprandial gastric volume in health and community dyspepsia? Neurogastroenterol Motil (2005) 1.03
Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil (2008) 1.02
Plasma vitamin K1 concentrations in cystic fibrosis. Arch Dis Child (1989) 1.02
Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment. BMJ (1995) 1.02
Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil (2006) 1.02
Stool microscopy in screening for steatorrhoea. J Clin Pathol (1977) 1.02
Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation. Aliment Pharmacol Ther (2013) 1.02
Two-year behavior outcomes of project towards no tobacco use. J Consult Clin Psychol (1995) 1.01
What are the most sensitive and specific sign and symptom combinations for influenza in patients hospitalized with acute respiratory illness? Results from western Kenya, January 2007-July 2010. Epidemiol Infect (2012) 1.01
Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther (2002) 1.00
Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin. Acta Paediatr Scand (1985) 1.00
Comparison of the diagnostic value of serum pancreatic isoamylase and immunoreactive trypsin measurement in patients with cystic fibrosis. J Clin Pathol (1982) 1.00
Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Endocrinol Metab (1983) 0.99
Breed relationships and definition in British cattle: a genetic analysis. Heredity (Edinb) (2004) 0.99
Comparison of treatments for congenital nonobstructive nonhaemolytic hyperbilirubinaemia. Arch Dis Child (1975) 0.98
Group self-identification and adolescent cigarette smoking: a 1-year prospective study. J Abnorm Psychol (1994) 0.98
Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary. J Clin Endocrinol Metab (1978) 0.97
An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis. J Clin Pathol (1988) 0.97
Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil (2011) 0.97
Health behavior changes through television: the roles of de facto and motivated selection processes. J Health Soc Behav (1993) 0.96
Functional interactions between GTP cyclohydrolase I and tyrosine hydroxylase in Drosophila. J Neurogenet (2000) 0.96
Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol Ther (2001) 0.96